Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Lynch

Orthopaedic Surgery Detroit, MI Medical Doctor

NPI 1336305291 CMS profile 241616

690 Amsterdam St, Detroit, MI 48202

Open in the dashboard

General payments

$221,315

256 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Lynch of Detroit, MI is reported in the CMS Open Payments database as having received $221,315 across 256 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46,558 34
2024 General $30,181 44
2023 General $9,361 8
2022 General $25,695 23
2021 General $26,931 22
2020 General $19,268 24
2019 General $63,320 101

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Lynch
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Thomas Lynch were reported at $46,558. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Thomas Lynch Orthopaedic Surgery median Middle half National median
2019 $63,320 $644 $140–$2,844 $163
2020 $19,268 $312 $75–$1,860 $114
2021 $26,931 $520 $117–$2,495 $132
2022 $25,695 $598 $128–$2,731 $149
2023 $9,361 $461 $128–$2,264 $160
2024 $30,181 $497 $134–$2,475 $164
2025 $46,558 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $125,651 136 payments
  2. Arthrex, Inc. $39,300 48 payments
  3. Linvatec Corporation $30,324 31 payments
  4. Djo, LLC $19,822 13 payments
  5. Gotham Surgical Solutions & Devices, Inc. $2,959 3 payments
  6. Pinnacle, Inc $1,880 17 payments
  7. KCI USA, Inc $1,000 2 payments
  8. Trilliant Surgical LLC. $136 1 payment
  9. MedShape, Inc. $119 1 payment
  10. Encore Medical, LP $50 1 payment
  11. Other $74 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $91,032 22 payments
  2. Consulting Fee $70,022 20 payments
  3. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $26,779 4 payments
  4. Travel and Lodging $20,965 67 payments
  5. Food and Beverage $9,623 141 payments
  6. Education $2,894 2 payments
Products named General payments · program years 2019–2025
  1. Q-FIX Extremities & Limb Restoration $32,112 13 payments
  2. LINVATEC HIP PRESERVATION SYSTEM $29,898 27 payments
  3. CAP-FIX $26,961 10 payments
  4. HEALICOIL $21,852 10 payments
  5. Q-FIX Sports Med Hip $17,017 18 payments
  6. MICRORAPTOR Sports Med Hip $15,895 13 payments
  7. Accu-pass $15,874 9 payments
  8. Bioraptor $15,124 8 payments
  9. MICRORAPTOR Sports Med Hip $13,874 8 payments
  10. DONJOY $13,604 2 payments
  11. Other $221,771 276 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$9,667

Medicare's payments for the services billed

Medicare patients

34

Average age 65

Services billed

69

21 women, 13 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 65%
Arthritis 62%
Diabetes 35%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

256 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record